Fractyl Health Announces Proposed Public Offering
Fractyl Health Announces Proposed Public Offering GlobeNewswire August 05, 2025 BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company pioneering pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (“T2D”), today announced that it intends to offer and sell, subject […]